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Environmental contamination has exposed humans to various metal agents, including mercury. This exposure is more common
than expected, and the health consequences of such exposure remain unclear. Formany years, mercury was used in a wide variety of
human activities, and now, exposure to this metal from both natural and artificial sources is significantly increasing. Many studies
show that high exposure to mercury induces changes in the central nervous system, potentially resulting in irritability, fatigue,
behavioral changes, tremors, headaches, hearing and cognitive loss, dysarthria, incoordination, hallucinations, and death. In the
cardiovascular system, mercury induces hypertension in humans and animals that has wide-ranging consequences, including
alterations in endothelial function. The results described in this paper indicate that mercury exposure, even at low doses, aﬀects
endothelial and cardiovascular function. As a result, the reference values defining the limits for the absence of danger should be
reduced.
1. History
More than 2500 A.C., the prehistoric man used the cinabrio
(mercury sulfide), due to its red-gold color, to draw on cave
walls and perform face painting. Subsequently, mercury has
been used in the amalgamation (direct burning of metallic
mercury on the gravel, promoting the separation of gold), in
photography and as an antiseptic in the treatment of syphilis
[1, 2].
Exposure to mercury brought harmful eﬀects to health
of humans, but changes resulting from human exposure to
mercury only called the attention of the scientific society
after the accidents in Japan and Iraq [3]. In Japan, a serious
accident occurred resulting from the deposition of industrial
waste with large quantities of mercury in the Minamata Bay.
Mercury was then ingested by human through fish intake,
thus triggering signs and symptoms such as ataxia, speech
impairment, visual field constriction, sensory disturbance,
deafness, blindness, tremors, involuntary movements, men-
tal retardation, coma, and death. Infants whosemothers were
infected developed mental retardation, peripheral neuropa-
thy, cerebral palsy, and blindness. These changes became
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known as Minamata disease or Russell-Hunter syndrome
[4, 5]. In Iraq, mercury poisoning occurred in 1971 when
wheat grains were treated with fungicides containing organic
mercury. This poisoning killed over 500 people who ate bread
made with contaminated wheat [6, 7].
2. Mercury Characteristics
Mercury is characterized as a highly malleable liquid at
normal temperature and pressure [8]. Its name is derived
from the Latin word hydrargyrum, meaning metal that
resembles liquid silver [8]. Mercury is classified into three
main groups: elemental mercury, inorganic mercury, and
organic mercury. Mercury exists in several forms: inorganic
mercury, among which There have been themetallic mercury
and mercury vapor (Hg0) and mercurous mercury (Hg+) or
mercuric mercury (Hg++) salts; organic mercury, also called
organometallic, which results from a covalent bond between
mercury and a carbon atom of an organic functional group
such as a methyl, ethyl, or phenyl group. The biological
behavior, pharmacokinetics, and clinical significance of the
various forms of mercury vary according to its chemical
structure [3].
2.1. Inorganic Mercury Compounds
2.1.1. Elemental Mercury or Metalic Mercury Compounds.
In its liquid form, the elemental mercury (Hg0) is poorly
absorbed and presents little health risk. However, in the
vapor form,metallic mercury is readily absorbed through the
lungs and can produce body damage [9–11]. Because of its
soluble characteristics, elemental mercury is highly diﬀusible
and is able to pass through cell membranes as well as the
blood-brain and placental barriers to reach target organs.
Once in the bloodstream, mercury undergoes catalase and
peroxidase-mediated oxidation in red blood cells and tissues
and is transformed into inorganic mercuric mercury (Hg++)
and mercurous mercury (Hg+), a process that limits its
absorption [9, 12]. Inorganic mercury has low lipophilicity
and thus has a limited ability to cross cell membranes [9].
Elemental mercury is used in thermometers and sphyg-
momanometers because of its uniform volumetric expan-
sion, high surface tension, and lack of vitreous adherence
to surfaces. Low electrical resistance and high thermal
conductivity allow metallic mercury to be used in electrical
and electronic materials. Because of its high oxidation power,
metallic mercury is used in electrochemical operations in
the chlorine and soda industries. Metallic mercury is also
used in metallurgy, mining, and dentistry because of the
easy amalgam formation with other metals. In addition, gold
extraction with archaic and dangerous methods predispose
miners to mercury poisoning. The burning of metallic
mercury on the gravel promotes the separation of gold, a
process called amalgamation, which causes emission of large
amounts of mercury vapor that is inhaled immediately by the
miner, since they do not use appropriate personal protective
equipment [13, 14].
Occupational exposure to mercury vapor and the release
of mercury from or during removal of amalgam dental
fillings increase its blood and plasma concentration [15, 16]
After exposure, blood concentrations attain 18 nmol/L [15],
and after exposure to dental and removal of amalgam fillings
plasma concentrations attain 5 nmol/L [17]. Occupational
exposure also aﬀects central nervous system [15] and
amalgam tooth fillings impair sheep kidney function [18].
However, toxicological consequences are still a matter of
debate [3, 19–23].
2.1.2. Mercurous Mercury and Mercuric Mercury Compounds.
The mercurous mercury in the form of mercurous chloride
(Hg2Cl2) is little absorbed in the body. It is believed that
in the body the form of metallic mercury is changed to
elemental mercury and mercuric mercury [24].
Mercuric mercury compounds, such as mercury salts,
result from the combination of mercury with chlorine,
sulfur, or oxygen. Mercuric mercury can be found in dif-
ferent states when combined with other chemical elements,
including mercuric chloride (HgCl2), which is highly toxic
and corrosive; mercury sulfide (HgS), which is often used as
a pigment in paints due to its red color; mercury fulminate
(Hg(CNO)2), which is used as an explosive detonator [8,
25]. Among the mercuric mercury compounds, mercuric
chloride (HgCl2) calls the attention. It was used as a
preservative for development of photographic film and has
been ingested accidentally or as a suicide measure [26].
As elemental mercury, the mercuric mercury in the blood
stream binds to sulfhydryl groups on erythrocytes, glu-
tathione, or metallothionein or is transported suspended in
plasma [27].Mercuric mercury accumulates in placenta, fetal
tissues, and amniotic fluid, but it does not cross the blood-
brain barrier eﬃciently [28]. Evidence exists showing the
transport of mercuric mercury via one or more amino acid
transporters [29]. Evidence also shows that the accumulation
in the brain occurs through its binding to cysteine [24].
In the cardiovascular system, acute inorganic mercury
exposition in vivo promotes reduction of myocardial force
development [30] and inhibited myosin ATPase activity
[31]. Chronic exposure increases vascular resistance and
induces hypertension [32–34]. Numerous studies have also
revealed that mercury generates oxygen free radicals mainly
by activation of NAPHoxidase [35, 36].
2.2. Organic Mercury. Organic mercury compounds, also
called organometallic, result from a covalent bond between
mercury and the carbon [8] atom of an organic func-
tional group such as a methyl, ethyl, or phenyl group.
Methylmercury (CH3Hg
+) is by far the most common
form of organic Hg to which humans and animals are
exposed. CH3Hg
+ in the environment is predominantly
formed by methylation of inorganic mercuric ions by
microorganisms present in soil and water [37–39]. The
expression methylmercury monomethylmercurial is used to
denote compounds that contain the cation methylmercury
(CH3Hg+). Some of these compounds were used as pesticides
and had medical applications as antiseptics and diuretics.
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The organomercury antiseptics still used are Merthiolate,
Bacteran, and Thimerosal [40].
Thimerosal is an organomercurial compound that since
1930 has been widely used as a preservative in biological
material such as vaccines and serums used to prevent
microbiological growth [41]. Thimerosal is metabolized in
the human body and degraded into ethylmercury and thios-
alicylate. The chemical diﬀerence between these compounds
is an important determinant of their toxicity [42, 43].
3. Forms of Mercury Exposure
Mercury is now considered an environmental pollutant of
high risk to public health because of its high toxicity and
mobility in ecosystems [11, 44]. Exposure to mercury can
occur from both natural and artificial sources. Human
activities that can result in mercury exposure include the
burning of fossil fuels, chlor-alkali industries, mining, the
burning of waste, and the use of coal and petroleum [10, 40,
45].
More natural sources of mercury include volcanic activ-
ity, earthquakes, erosion, and the volatilization of mercury
present in the marine environment and vegetation [10, 46–
48]. Mercury emitted both naturally or as a result of human
activity is primarily found as inorganic metal vapor (Hg0)
[49]. Among the natural sources of mercury, the largest
emissions are from the degassing of the earth’s crust. More
than five tons of mercury is estimated to be released into the
sea every year as a result of erosion and geochemical cycles
[50].
Mercury contaminates the environment through a cycle
involving the initial emission, the subsequent atmospheric
circulation of the vapor form, and the eventual return of
mercury to the land and water via precipitation (Figure 3)
[46]. The emission of mercury is an important part of
this cycle of contamination and can occur through natural
processes or as a result of human activities, as mentioned
above [48].
Mercury present in seas and rivers after methylation
can contaminate fish [51, 52]. The consumption of fish
contaminated with mercury is a major source of mercury
exposure in the Amazon basin. Studies show that the
concentration of mercury in the muscles of fish that are
widely consumed in the Amazon region are greater than the
limit set by WHO (World Health Organization) as safe for
human consumption (0.5 g/kg) [4, 10].
4. Transport and Elimination of Mercury
Inhaled elemental mercury vapor, for example, is readily
absorbed through mucous membranes and the lung and
is rapidly oxidized but not as quickly as to prevent the
deposition of considerable amount in the brain [54].
Methylmercury is easily absorbed through the gut, and it
is deposited in most tissue but does not cross the blood-
brain barrier as eﬃciently as elemental mercury. However, to
enter the brain, it is progressively demethylated to elemental
mercury (Figure 2) [24]. Mercury salts, in contrast, tend to
be insoluble, relatively stable, and hardly absorbed.
Then, toxicity for man varies depending on the form
of mercury, dose, and rate of exposure. The target organ
for inhalted mercury vapor is primarily the brain [24].
Mercurous and mercury salts especially damage the lining
of the intestine and kidneys [5], and as methyl mercury,
it is widely distributed throughout the body (Figure 1)
[24]. Toxicity varies with dosage; a large acute exposure to
elemental mercury vapor induces severe pneumonia, which
in extreme cases can be fatal [24]. Low level of chronic
exposure to elemental or other forms of mercury induces
more subtle symptoms and clinical findings [3].
Oxidized mercury binds strongly to SH groups; this
reaction can inactivate enzymes, lead to tissue damage
and interfere with various metabolic processes [55–57].
Ingested methylmercury is almost completely absorbed
and transported into the bloodstream [10]. Methylmercury
enters cells mainly by forming a complex with L-cysteine
and homocysteine and is eliminated in conjunction with
glutathione [58]. After absorption, it is distributed primarily
to the central nervous system and kidneys. Methylmercury
elimination usually occurs in the urine and feces [59].
5. Doses of Mercury and Safety Legislation
The chemical form of mercury in the air aﬀects its time
of permanence and its dispersion in the atmosphere. The
elemental mercury form can persist for more than four years
in the air, while its compounds are deposited in a short time
at locations near their origin. In the northern hemisphere,
their average concentration in the atmosphere is estimated
at 2 ng/m3 and in the southern hemisphere is less than
1 ng/m3. In urban areas, there is a great variability of these
concentrations being found up to 67 ng/m3 with a mean of
11 ng/m3 in Japan [53]. FUNASA (Fundac¸a˜o Nacional de
Sau´de) standards of mercury in the air consider a mean of
1 ng/m3 in the period of one year [60].
In 2004, the Joint FAO (Food and Agriculture Organi-
zation of the United National)/WHO Expert Committee on
Food Additives (JECFA) established that the safe concen-
tration of methylmercury intake, without the appearance
of neurological disorders, is 1.6mg/kg of body weight.
However, in 2006, JECFA stated that this concentration is
not safe for intrauterine exposure, because fetuses are more
sensitive to the onset of neurological disorders after exposure
to methylmercury [61].
Currently, the general population is exposed to mercury
by the following main sources: the consumption of contam-
inated fish, the use and manipulation of dental amalgam,
thimerosal contained in vaccines, workers in industries of
chlorine, caustic soda, miners, and workers in industries of
fluorescent lamps [62, 63]. Each of these sources of exposure
contains specific toxicological characteristics [64].
In Brazil, the rules for vaccination of the Ministry of
Health, published in June 2001, shows that thimerosal is used
in many vaccines. These vaccines prevent flu (influenza vac-
cine), rabies (rabies vaccine), infection with meningococcus
serogroup b, and hepatitis B [65].
The US Environmental Protection Agency’s recom-
mended a reference blood concentration of mercury to be
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Figure 1: Scheme showing the entry of elemental mercury in organisms and their distribution in diﬀerent organs.
Organic
Gastrointestinal
tract
Erythrocyte (−SH )
Liver/intestine
MeHg
MeHg
MeHg
Hg++
Hg++
Central nervous
system
Cardiovascular
system
system
Kidney
Reproductive
system Respiratory
Figure 2: Scheme showing the entry of organic mercury in organisms and their distribution in diﬀerent organs.
5.8 ng/mL; concentrations below this level are considered to
be safe [66, 67]. Some studies have reported that the blood
mercury concentration in the control population is approx-
imately 1 ng/mL. On the other hand, levels of 7–10 ng/mL
have been reported in workers exposed to mercury or in
residents of Guizhou (China), an area that is known to suﬀer
mercury contamination [68, 69]. In a recent biomonitoring
study in New York City, the blood mercury concentration
was found to be 2.73 ng/mL, and levels reached 5.65 ng/mL
in adults that consumed fish regularly [70].
WHO [10] states that an allowable concentration of
mercury in human hair is less than 6 μg/g. In the Amazon
basin, where fish is the main source of dietary protein,
mercury concentrations in hair reached up to 150 μg/g.
Furthermore, only two of 40 cities studied have average
mercury concentrations below the recommended amount
[10, 71]. In individuals who have amalgam, the daily release
of mercury amalgam is approximately 4-5 μg/day, and a
positive correlation exists between the blood concentration
of mercury and the number of amalgams. It is estimated that
each dental amalgam releases 3–17 μg mercury vapor per day
and that the blood concentration of mercury after removal
of the restoration can reach 5 nmol/L [72–74]. However,
even at concentrations below recommended levels, there is
strong evidence that exposure to ethyl mercury, the major
component of thimerosal, is associated with the onset of
neurological and heart disorders in children [75].
In the following sections, we will describe results
obtained from animals with chronic and acute exposure
to mercury. Some of these studies were performed with
mercury exposure protocols that led to blood concentrations
slightly above the reference values. Nevertheless, these con-
centrations could be easily found in exposed populations
and may even be considered low when compared with
concentrations in humans who consume large amounts of
fish or who live in areas contaminated with mercury.
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6. Effect of Mercury on the Central
Nervous System (CNS)
Among the compounds of mercury, the methylmercury is
primarily responsible for the neurological alterations present
in humans and experimental animals. It is believed that
the mechanisms are related to the toxic increase in reactive
oxygen species (ROS). Oxidative stress is associated with the
etiology of neurodegenerative diseases such as amyotrophic
lateral sclerosis, Parkinson’s disease, and Alzheimer’s disease
[54, 55], but these mechanisms have yet to be fully recog-
nized.
Reinforcing the hypothesis that the majority of injuries
caused by methylmercury (MeHg) in the central nervous
system are related to its ability to increase reactive oxygen
species, Zhang et al. (2009) [20] reported that after pre-
treatment of bovine cells with pyrroloquinoline quinone
(PQQ), an antioxidant, the cytotoxicity induced by MeHg
is significantly attenuated. PQQ reduces the percentage
of apoptotic cells, decreased significantly ROS production,
suppressed lipid peroxidation, and increased antioxidant
enzyme activity in cells exposed to MeHg. Furthermore,
the protective eﬀects elicited by an antioxidant (ebselen)
strengthen the idea that seleno-organic compounds rep-
resent promising approaches to neutralize MeHg-induced
neurotoxicity [19].
Studies also demonstrate that mercury has the ability
to reduce the number of neuron and cytoarchitecture in
individuals with prenatal exposure to mercury [76, 77]. In
animal models, some of these symptoms are reproduced.
Low-dose prenatal exposure to methylmercury during 10
gestational days impairs motor and mnemonic function in
adult mice [23]. This hypothesis is supported by studies
that describe methylmercury inhibition of cell division and
migration both “in vivo” and “in vitro” [76–78].
In addition, because of its high aﬃnity for sulfhydryl
groups in tubulin, methylmercury inhibits the organization
of microtubules that are important in CNS development
[79–81]. The binding to SH groups also interferes with the
intracellular signaling of multiple receptors (e.g., muscarinic,
nicotinic, and dopaminergic) and promotes the blockade of
Ca++ channels in neurons [82, 83]. In addition, inorganic
mercury has the ability to increase the permeability of
chloride channels of GABA A receptors in the dorsal root
ganglion, which is associated with neuronal hyperpolariza-
tion [84].
Corroborating these findings, the study conducted by
Maia et al., (2010) [21] demonstrates that the poisoning
by methylmercury changes the nitrergic activities of adult
mice, and the predominance of alterations may be related
to diﬀerent locations. Besides increasing the nitrergic activ-
ity methylmercury and mercuric chloride also have the
ability to increase the release of neurotransmitters such
as acetylcholine, dopamine, norepinephrine, and serotonin.
Similar findings have also been reported to be a mechanism
implicated in the eﬀects of methylmercury and HgCl2 on the
central nervous system function [85–89].
Halbach et al. [90] studied a correlation in Iraqi children
between the level of maternal exposure to methylmercury
during pregnancy and psychomotor retardation. Sandborgh-
Englund et al. [91] corroborated this finding in children
from the Faroe Islands; they found that children exposed
to mercury in the prenatal period had defects in atten-
tion, memory, language, and motor function. In addition,
exposure to methylmercury in pregnant women or early
childhood leads to changes in the CNS development of the
fetus or child, respectively [50, 92, 93]. Thereupon, changes
caused by mercury poisoning result in significant clinical
deficit in motor skills, coordination, and general activity rate
of cognitive and psychological disorders [23].
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7. Effect of Mercury on
the Cardiovascular System
For decades, the toxic eﬀects of mercury were associated
mainly with the central nervous system; however, inorganic
mercury also produces profound cardiotoxicity [94–99].
Halbach and collaborators [100] showed that mercury
concentrations in hair reached up to 150 μg/g in populations
living in the Amazon basin. Furthermore, nearly all of the
inhabitants of 40 cities studied have blood concentrations
above the reference values. In this population, it has
been demonstrated that exposure to mercury by frequent
consumption of fish has a strong positive correlation with
increased arterial blood pressure [101]. Other studies also
correlate mercury exposure with increased risk of hyper-
tension, myocardial infarction, coronary dysfunction, and
atherosclerosis [102–105]. Data presented by Yoshizawa et
al. [106] showed that mercury exposure was associated
with the progression of atherosclerosis and an increased
risk of developing cardiovascular disease. Houston [107]
followed patients for approximately 13.9 years and found an
association between the concentration of mercury in the hair
and the risk of developing cardiovascular events or dying
from cardiovascular disease and other causes.
Mercury levels are predictors of the levels of oxidized
low-density lipoprotein (LDL) [106]. Oxidized LDL particles
are frequently found in atherosclerotic lesions and are
associated with the development of atherosclerotic disease
[107, 108] and acute coronary insuﬃciency [109]. Another
mechanism by which mercury exerts toxic eﬀects on the
cardiovascular system is through the inactivation of the
“paraoxonase” [110], an enzyme that slows the LDL oxida-
tion process and that has an important antiatherosclerotic
action [101].
The mechanism by which mercury produces toxic eﬀects
on the cardiovascular system is not fully elucidated, but this
mechanism is believed to involve an increase in oxidative
stress. Exposure to mercury increases the production of free
radicals, potentially because of the role of mercury in the
Fenton reaction [111–113] and a reduction in the activity
of antioxidant enzymes, such as glutathione peroxidase. The
MeHg reaction with the glutathione peroxidase occurs via
thiol (–SH) and/or selenol (–SeH) groups from endogenous
molecules [114]. Even though there are 4 of glutathione
molecules containing selene in their active sites, only the
cytoplasmic glutathione peroxidase 1 (GPx 1) changes
hydrogen peroxide to water [115, 116].
The reduction in glutathione peroxidase with selenium-
dependent activity is the result of the decreased bioavailabil-
ity of selenium, a molecule that is required for enzymatic
activity [117–119]. The high aﬃnity of mercury to the
thiol group can lead to decreased glutathione peroxidase
selenium-dependent activity. Other antioxidant enzymes
which participate against reactive oxygen species due to
mercury intoxication are catalase and superoxide dismutase.
The increment of ROS and reduction of the antioxidant
activity increase the risk of developing cardiovascular disease
[118, 120, 121].
Sherwani et al. (2011) [122] showed that MeHg has
the capacity to induce phospholipase D (PLD) activation
through oxidative stress and thiol-redox alterations. They
investigated the mechanism of the MeHg-induced PLD acti-
vation through the upstream regulation by phospholipase A2
(PLA2) and lipid oxygenases such as cyclooxygenase (COX)
and lipoxygenase (LOX) in the bovine pulmonary artery
endothelial cells. Their results showed that MeHg signifi-
cantly activates both PLA2 and PLD. MeHg also induces
the formation of COX- and LOX-catalyzed eicosanoids in
endothelial cells.
Cardiovascular changes resulting from mercury poison-
ing are also described in animal models. However, the
mechanism involved in the eﬀects of mercury on the
cardiovascular system is not fully understood but seems
to be dependent on both the dose and time of exposure.
Raymond and Ralston [123] studied the hemodynamic
eﬀects of an intravenous injection of HgCl2 (5 mg/kg) in rats
and observed that mercury produced cardiac diastolic failure
and pulmonary hypertension. Moreover, Naganuma et al.
[124] reported that acute exposure to HgCl2 (680 ng/kg)
increased blood pressure, heart rate, and vascular reactivity
to phenylephrine in rats; this increased reactivity seems to
depend on an increased generation of free radicals. Perfused
hearts from animals exposed acutely to HgCl2 showed a
reduction in left ventricular systolic pressure, heart rate, and
atrioventricular conduction delay [125, 126].
Our group has found that chronic exposure to low doses
of mercury (1st dose 4.6 μg/kg followed by 0.07 μg/kg/day
for 30 days, im) attained a blood mercury concentration
of approximately 8 ng/mL, a concentration similar to the
levels found in exposed humans. This exposure produced
a negative inotropic eﬀect in perfused hearts, although
increasing myosin ATPase activity. Invivo, arterial or ven-
tricular pressures did not change [127]. The reduction
in contractility was explained by alterations in calcium-
handling mechanisms; protein expression of SERCA, Na+
K+ ATPase (NKA), and sodium/calcium exchanger (NCX)
was diminished; phospholamban (PLB) expression was
increased; the response to β-adrenergic stimulation was
reduced following mercury exposure [128, 129].
The chronic exposure to low concentrations of mer-
cury was also able to induce endothelial dysfunction in
resistance and conductance vessels, most likely because
of the decreased nitric oxide (NO) bioavailability due to
the increased superoxide anion (O2
•−) production from
NADPH oxidase [36, 130, 131]. This study was evidenced by
the following eﬀects of mercury treatment observed in aorta,
coronary, and mesenteric arteries: (1) the endothelium-
dependent vasodilator response induced by acetylcholine
(ACh) was decreased [36, 130]; (2) vasoconstrictor responses
to phenylephrine or serotonin were increased, and NO
endothelial modulation of these responses was decreased
[36, 130, 131]; (3) vascular superoxide anion produc-
tion, the expression of SOD-2, NOX-1, and NOX-4 (two
main isoforms of NADPH oxidase), plasmatic malondi-
aldehyde levels, and plasmatic antioxidant status were all
increased [36, 130]; (4) both the superoxide anion scavenger
SOD and the NADPH oxidase inhibitor apocynin restored
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the NO endothelial modulation of vasoconstrictor responses
and the impaired ACh-induced vasodilatation in vessels
from the mercury-treated rats [36, 130]. We also observed
that mercury treatment increased the participation of COX-
2-derived vasoconstrictor prostanoids in vasoconstrictor
responses [132]. Other researchers have also observed a
selective loss of NO-mediated vasodilatation with no eﬀect
on the EDHF-mediated component of relaxation, implying
that chronic mercury exposure selectively impairs the NO
pathway as a consequence of oxidative stress, while EDHF
is able to maintain endothelium-dependent relaxation at a
reduced level [133]. On the other hand, using this low dose
of mercury, Blanco-Rivero et al. [134] observed an increase
in vasoconstriction responses to electrical field stimulation
mediated by alterations of adrenergic and nitrergic function
in rat mesenteric arteries. HgCl2 reduced neuronal NO
bioavailability, most likely as a result of reduced nNOS
(neuronal nitric oxide synthase) activity and increased O2
−
production as well as increased noradrenaline release and
vasoconstrictor response. It is important to emphasize,
regarding chronic low-dose exposure to mercury for 30
days, that although rats grow normally and have no changes
in arterial blood pressure, endothelial function is already
blunted aﬀecting vascular reactivity [36, 131].
Taken together, these data show that chronic low doses
of mercury have an important and deleterious eﬀect on
vascular function by reducing NO bioavailability. The degree
of severity of mercury exposure is comparable to traditional
cardiovascular risk factors, such as hypertension diabetes or
hypercholesterolemia. Therefore, mercury could be consid-
ered an important risk factor for cardiovascular disease that
could play a role in the development of cardiovascular events.
The association between mercury exposure and an increased
risk of developing cardiovascular and neurological diseases
is apparent. Thus, continuous exposure to mercury can be
dangerous, and current reference values, once considered to
be without risk, should be reevaluated and reduced.
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